123 related articles for article (PubMed ID: 11380485)
1. Aromatase regulation and breast cancer.
Reed MJ; Purohit A
Clin Endocrinol (Oxf); 2001 May; 54(5):563-71. PubMed ID: 11380485
[No Abstract] [Full Text] [Related]
2. Biology of aromatase inhibitors: pharmacology/endocrinology within the breast.
Miller WR
Endocr Relat Cancer; 1999 Jun; 6(2):187-95. PubMed ID: 10731108
[TBL] [Abstract][Full Text] [Related]
3. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
4. Aromatase and COX-2 expression in human breast cancers.
Brodie AM; Lu Q; Long BJ; Fulton A; Chen T; Macpherson N; DeJong PC; Blankenstein MA; Nortier JW; Slee PH; van de Ven J; van Gorp JM; Elbers JR; Schipper ME; Blijham GH; Thijssen JH
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):41-7. PubMed ID: 11850206
[TBL] [Abstract][Full Text] [Related]
5. Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk?
Nebert DW
J Natl Cancer Inst; 1993 Dec; 85(23):1888-91. PubMed ID: 8230275
[No Abstract] [Full Text] [Related]
6. 16-Hydroxylation of estrogens in pigmented and albino guinea-pigs.
Hobkirk R; Mori J; Nilsen M
J Steroid Biochem; 1980 Aug; 13(8):945-50. PubMed ID: 7464140
[No Abstract] [Full Text] [Related]
7. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Miller WR; Stuart M; Sahmoud T; Dixon JM
Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
[TBL] [Abstract][Full Text] [Related]
8. Aromatase and breast cancer.
Brodie A; Sabnis G; Jelovac D
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):97-102. PubMed ID: 17113978
[TBL] [Abstract][Full Text] [Related]
9. Aromatase inhibitors and inactivators in breast cancer.
Lønning PE
BMJ; 2001 Oct; 323(7318):880-1. PubMed ID: 11668120
[No Abstract] [Full Text] [Related]
10. Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.
Lønning PE; Haynes BP; Dowsett M
Eur J Cancer; 2014 Apr; 50(6):1055-64. PubMed ID: 24507547
[TBL] [Abstract][Full Text] [Related]
11. Determination of estradiol 2- and 16-alpha-hydroxylase activities in MCF-7 human breast cancer cells in culture using radiometric analysis.
Niwa T; Bradlow HL; Fishman J; Swaneck GE
J Steroid Biochem; 1989 Aug; 33(2):311-4. PubMed ID: 2770303
[TBL] [Abstract][Full Text] [Related]
12. New aromatase inhibitors in the treatment of advanced breast cancer.
Crucitta E; Lorusso V; Attolico M; Sambiasi D; Mazzei A; De Lena M
Int J Oncol; 2000 Nov; 17(5):1037-41. PubMed ID: 11029510
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of aromatase inhibitors in the treatment of breast cancer.
Harvey HA
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk.
Osborne MP; Bradlow HL; Wong GY; Telang NT
J Natl Cancer Inst; 1993 Dec; 85(23):1917-20. PubMed ID: 8230281
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific synthesis and oxidative metabolism of estrogens.
Jefcoate CR; Liehr JG; Santen RJ; Sutter TR; Yager JD; Yue W; Santner SJ; Tekmal R; Demers L; Pauley R; Naftolin F; Mor G; Berstein L
J Natl Cancer Inst Monogr; 2000; (27):95-112. PubMed ID: 10963622
[TBL] [Abstract][Full Text] [Related]
16. Letrozole in breast cancer.
Shahab N
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971058
[No Abstract] [Full Text] [Related]
17. Letrozole in breast cancer.
Hietanen P; Mäkelä M
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971057
[No Abstract] [Full Text] [Related]
18. Influence of estrogen metabolism on proliferation of human breast cancer.
Imoto S; Mitani F; Enomoto K; Fujiwara K; Ikeda T; Kitajima M; Ishimura Y
Breast Cancer Res Treat; 1997 Jan; 42(1):57-64. PubMed ID: 9116318
[TBL] [Abstract][Full Text] [Related]
19. The Letrozole Breast Cancer Trial: clinical implications and remaining questions.
Chen WY; Manson JE
Womens Health Issues; 2004; 14(1):7-10. PubMed ID: 15001182
[No Abstract] [Full Text] [Related]
20. Letrozole in breast cancer.
Harris SR
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971059
[No Abstract] [Full Text] [Related]
[Next] [New Search]
